Teriparatide-denosumab combo shows promise for osteoporosis

05/15/2013 | HealthDay News

Combining teriparatide and denosumab was more effective than using the drugs alone in increasing bone density in postmenopausal women with osteoporosis, a small study found. The combination also was more effective than any drugs on the market today, the study author said. The findings appeared online in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX